Upgrade to SI Premium - Free Trial

Kymera Therapeutics (KYMR) PT Raised to $136 at Truist Securities

June 29, 2026 7:12 AM
(Updated - June 29, 2026 9:29 AM EDT)

Truist Securities analyst Srikripa Devarakonda raised the price target on Kymera ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change